Evolution of the Average Target: VTEX

Evolution of the Target Price: VTEX

Changes in Analyst Recommendations: VTEX

f47863bbfa34d60198.8V5FDuZnJCp-EMbq4I9rAOOUiiKYSct4Q4psBG6yh2w.uA4xV48JYUE7KYu-q7sOcNbj4mjdGLgUKtwPSyDitljBJwN70ylQfzckgw~f86738a06c9f88aa13549a945fe341c4
01-15 VTEX Shares Fall After UBS Downgrade MT
01-15 UBS Downgrades VTEX to Neutral From Buy, Adjusts Price Target to $4 From $8 MT
16/10/25 Goldman Sachs Initiates Coverage on VTEX With Buy Rating, $5.30 Price Target MT
17/09/25 VTEX Shares Rise After Jefferies Upgrade MT
17/09/25 Jefferies Upgrades VTEX to Buy From Hold, Price Target is $6.50 MT
08/08/25 JPMorgan Downgrades VTEX to Neutral From Overweight, Trims Price Target to $6 From $7.50 MT
07/08/25 VTEX Q2 revenue misses estimates RE
22/05/25 Jefferies Initiates VTEX at Hold With $7.30 Price Target MT
20/12/24 UBS Adjusts VTEX Price Target to $11 From $12.50, Maintains Buy Rating MT
06/12/24 Citigroup Initiates VTEX at Neutral With $6.70 Price Target MT
12/08/24 UBS Adjusts Price Target on VTEX to $12.50 From $12, Maintains Buy Rating MT
14/05/24 VTEX Shares Jump After Upgrade From J.P. Morgan MT
14/05/24 JPMorgan Upgrades VTEX to Overweight From Neutral, Price Target is $9 MT
25/03/24 UBS Adjusts VTEX Price Target to $12 From $8.50, Maintains Buy Rating MT
05/01/24 Morgan Stanley Upgrades VTEX to Overweight From Equalweight, Adjusts Price Target Price Target to $8 From $5.50 MT
20/11/23 UBS Adjusts VTEX Price Target to $8.50 From $7.50 Maintains Buy Rating MT
08/11/23 Piper Sandler Adjusts Price Target on VTEX to $7 From $6, Maintains Overweight Rating MT
23/08/23 UBS Upgrades VTEX to Buy From Neutral, Adjusts Price Target to $7.50 From $4.70 MT
09/08/23 Piper Sandler Adjusts Price Target on VTEX to $6 From $5, Maintains Overweight Rating MT
10/05/23 Itau BBA Upgrades VTEX to Outperform From Market Perform With $6 Price Target MT
09/03/23 DA Davidson Initiates VTEX at Buy With $5 Price Target MT
20/12/22 Piper Sandler Cuts Price Target on VTEX to $5 From $6, Reiterates Overweight Rating MT
19/12/22 Morgan Stanley Downgrades VTEX to Equalweight From Overweight, Adjusts Price Target to $5 From $7 MT
02/11/22 UBS Adjusts VTEX Price Target to $4.70 From $4.30, Maintains Neutral Rating MT
20/10/22 UBS Initiates VTEX at Neutral with $4.30 Price Target MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.63%
+7.08%
+12.54%
+24.68%
+36.26%
+24.94%
+18.68%
+13.23%
-0.47%
Average +16.84%
Weighted average by Cap. +14.52%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.810USD
Average target price
5.960USD
Spread / Average Target
+56.43%
High Price Target
12.00USD
Spread / Highest target
+214.96%
Low Price Target
4.100USD
Spread / Lowest Target
+7.61%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Goldman Sachs
Jefferies & Co.
JPMorgan Chase
Citigroup
Morgan Stanley
Piper Sandler
Itau BBA
DA Davidson
BofA Securities
KeyBanc Capital Markets
Credit Suisse
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.810USD
Average target price
5.960USD
Spread / Average Target
+56.43%

Quarterly revenue - Rate of surprise